Details of the Drug Reposition

General Information of This Drug (ID: DMY5V4U)

• Drug Name: CM-CS1 T-cell (DMY5V4U)
• Drug Type: CAR T Cell Therapy

Information on Drug Reposition of This Drug

3 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Myelodysplastic syndrome	DISYHNUI	2A37	Phase 1	[1]
Acute myeloid leukaemia	DIS0BM1I	2A60	Phase 1	[1]
Multiple myeloma	DISEWP9B	2A83	Phase 1	[1]

References

• [1] ClinicalTrials.gov (NCT02203825) Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands